RxPost

RxPost

Private
Los Angeles, CaliforniaHealthcare & Life Scienceshttps://rx-post.com

Last Round

Pre Seed

Feb 6, 2025

Est. Valuation

$3M

Total Funding Raised

$2.18M

Momentum Score

50 /100

Company Overview

RxPost is a healthtech company that provides a DSCSA-compliant digital marketplace and inventory management platform designed to help independent pharmacies buy and sell surplus medication inventory.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Vertical SaaS, E-commerce, Compliance

Business Model

B2B

Customer Profile

Marketplace Commission, Subscription SaaS, Freemium

AI Layer

Non-AI

Keywords

pharmacy marketplaceB2B marketplaceDSCSA complianceDSCSAindependent pharmacysurplus medicationdrug liquidationpharmacy inventory managementmedication shortage solutionpharmaceutical redistributionpharma supply chainDrug Supply Chain Security Actvertical SaaStransaction fees

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RxPost Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

RxPost Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Pre SeedFeb 6, 2025
GrantNov 7, 2024
AcceleratorMar 12, 2024

RxPost Investors

Notable investors and investment history

InvestorRounds
Catalyst FundPre Seed
Capitalize VCPre Seed
Fabric VCPre Seed
Women Founders NetworkGrant
Slauson & Co.Pre Seed, Accelerator
The Bond FundPre Seed
Future Communities CapitalPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Monthly visitors grew 64% MoM, reaching 4.6K.

RxPost Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

RxPost Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about RxPost's valuation, stock price, and market status.

Firmographic Details

HeadquartersLos Angeles, California
Employee Range15
Year Founded2021
Last FundingFeb 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.